UC UC UC UC UC UC UC UC UC UC UC .../ DE000HR52296 /
31/05/2024 21:45:57 | Diferencia+0.140 | Bid21:59:35 | Ask21:59:35 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
11.630EUR | +1.22% | 11.650 Volumen de oferta: 1,000 |
11.740 Tamaño/ Volumen/ Formato de Ask: 1,000 |
GENERALI | 12.0334 EUR | 31/12/2078 | Call |
GlobeNewswire
2:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página